Plavix 75 mg is an original antiplatelet medication containing clopidogrel. The drug inhibits platelet aggregation, effectively preventing the formation of dangerous blood clots in blood vessels. It is used for the reliable secondary prevention of atherothrombotic and thromboembolic events in patients with cardiovascular diseases.

Indications: Plavix 75 mg is used for:

• Prevention of recurrent myocardial infarction and ischemic stroke

• Prevention of thrombosis in patients with established peripheral arterial disease

• Management of acute coronary syndrome (in combination with acetylsalicylic acid)

• Prevention of coronary stent thrombosis following percutaneous coronary intervention (PCI)

• Reduction of vascular events in patients with atrial fibrillation

Reasons for Use:

• Recent myocardial infarction or ischemic stroke

• Presence of coronary stents or prior vascular surgery

• Diagnosed peripheral arterial disease

• Need for effective long-term antiplatelet protection

Key Features:

• Active ingredient — clopidogrel hydrogen sulfate (75 mg)

• Selectively and irreversibly blocks platelet P2Y12 receptors, preventing aggregation

• Provides a stable, long-lasting antithrombotic effect with once-daily dosing

• Improves blood flow properties and normalizes microcirculation

• Standard 30 film-coated tablet pack for a 1-month treatment course

Dosage Form: Plavix — film-coated tablets, 75 mg (pack of 30 tablets)

Manufacturer: Sanofi Winthrop Industrie / Sanofi-Aventis (France / Israel)

Active Ingredients:

• Clopidogrel — 75 mg

#Plavix #Plavix75 #Clopidogrel #Antiplatelet #HeartHealth #StrokePrevention #Sanofi #IsraeliMeds #PharmacyIsrael #Cardiology